Post Market Observational, Prospective, Multi-center Study

July 15, 2021 updated by: Boston Scientific Corporation

Post Market Observational, Prospective, Multi-center Registry Using the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) System

This registry is a post market observational, prospective, multi-center registry.

It is designed to evaluate patient experience with the endobronchial coil system for the relief of the emphysema symptoms and the continued collection of safety and effectiveness data on this CE Mark product.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Terminated

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
1275

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Austria
      • Wien, Austria, 1140
        • Otto-Wagner-Spital
  • Denmark
      • Copenhagen, Denmark, 2100
        • Rigshospitalet Copenhaven
  • Germany
      • Bad Homburg, Germany, 61352
        • Hochtaunus-Kliniken, Klinik für Pneumolog und Onkologie
      • Berlin, Germany, 10117
        • Charité Campus Mitte
      • Berlin, Germany, 13353
        • Charité Campus Virchow-Klinikum
      • Berlin, Germany, 14089
        • Gemeinschaftskrankenhaus Havelhöhe
      • Berlin-Zehlendorf, Germany, 14165
        • Helios Klinikum Emil von Behring, Berlin
      • Bonn, Germany, 53105
        • Universitätsklinikum Bonn
      • Bovenden, Germany, 37120
        • Ev. Krankenhaus Göttingen-Weende
      • Bremerhaven, Germany, 27574
        • DRK Klinik am Bürgerpark
      • Burghausen, Germany, 84489
        • Kreiskliniken Altötting-Burghausen
      • Donaueschingen, Germany, 78166
        • Schwarzwald-Baar-Klinikum
      • Donaustauf, Germany, 93093
        • Klinik Donaustauf
      • Dortmund, Germany, 44145
        • Medizinische Klinik Nord
      • Duisburg, Germany, 47166
        • Helios Klinikum Duisburg
      • Duisburg, Germany, 47228
        • Johanniter KH Duisburg Rheinhausen
      • Elgershausen, Germany, 35753
        • Pneumologische Klinik Waldhof Elgershausen
      • Essen, Germany, 45239
        • Ruhrlandklinik
      • Frankfurt am Main, Germany, 60487
        • St. Elisabethen Krankenhaus
      • Frankfurt am Main, Germany, 60487
        • Bethanien Krankenhaus
      • Fürth, Germany, 90766
        • Klinikum Fürth
      • Gauting, Germany, 82131
        • Asklepios-Klinikum Gauting
      • Gera, Germany, 07548
        • SRH Wald-Klinikum Gera GmbH
      • Greifswald, Germany, 17475
        • Universitätsmedizin Greifswald
      • Halle, Germany, 06120
        • Universitätsklinikum Halle
      • Halle, Germany, 6114
        • Diakoniekrankenhaus Halle
      • Hamburg, Germany, 20246
        • Uniklinik Eppendorf
      • Hamburg, Germany, 22291
        • Asklepios Klinik Barmbeck
      • Harburg, Germany, 21075
        • Asklepios
      • Hemer, Germany, 58675
        • Lungenklinik
      • Immenhausen, Germany, 34376
        • Lungenfachklinik Immenhausen
      • Kempten, Germany, 87439
        • Klinikverbund Kempten-Oberallgäu
      • Koblenz, Germany, 56073
        • Marienhof Koblenz
      • Krefeld, Germany, 47805
        • Helios Klinikum Krefeld
      • Köln, Germany, 50668
        • St. Marien-Hospital
      • Lostau, Germany, 39291
        • Lungenklinik Lostau
      • Lübeck, Germany, 23538
        • Universitätsklinikum Schleswig-Holstein
      • Magdeburg, Germany, 39120
        • Universitätsklinikum Magdeburg
      • Mainz, Germany, 55131
        • Katholisches Klinikum Mainz
      • München, Germany, 81479
        • Krankenhaus Martha-Maria
      • München, Germany, 81545
        • Städt. Klinikum München-Harlaching
      • München, Germany, 81925
        • Städt. Klinikum München-Bogenhausen
      • Neuruppin, Germany, 16816
        • Ruppiner Kliniken GmbH
      • Paderborn, Germany, 33098
        • Brüderkrankenhaus St. Josef Paderborn
      • Regensburg, Germany, 93053
        • Universitätsklinikum
      • Rosenheim, Germany, 83022
        • RoMed Klinikum Rosenheim
      • Schwerin, Germany, 19049
        • Helios Kliniken Schwerin
      • Solingen, Germany, 42699
        • Krankenhaus Bethanien Solingen
      • Stuttgart, Germany, 70372
        • Krankenhaus vom Roten Kreuz
      • Ulm, Germany, 89081
        • Universitätsklinikum Ulm
      • Völklingen, Germany, 66333
        • Saarland Heilstätten GmbH
      • Wuppertal, Germany, 42282
        • Petrus-Krankenhaus
      • Würselen, Germany, 52146
        • Medizinisches Zentrum Städte Region Aachen GmbH
  • Spain
      • Barcelona, Spain
        • Centro Médico Teknon
      • Bilbao, Spain
        • Hospital de Basurto
      • Madrid, Spain
        • Fundacion Jimenez Diaz
      • Madrid, Spain, 28223
        • Hospital Universitario Quirón
      • Malaga, Spain
        • Hospital Quirón
      • Valencia, Spain, 46026
        • Hospital Universitario Y Politecnico La Fe
  • Switzerland
      • Bern, Switzerland, CH-3010
        • Inselspital
      • Geneve, Switzerland, 1211
        • Hopitaux Universitaires de Geneve (HUG)
      • Lausanne, Switzerland, 1011
        • CHUV
      • Neuchâtel, Switzerland, 2000
        • L'hôpital Neuchâtelois - Pourtalès
      • St. Gallen, Switzerland, 9007
        • Kantonsspital Sankt Gallen
      • Zürich, Switzerland, 8091
        • Universitatsspital Zurich
      • Zürich, Switzerland, 8032
        • LungenZentrum Hirslanden
  • United Kingdom
      • Birmingham, United Kingdom, B9 4 LS
        • Heartlands Birmingham
      • Bristol, United Kingdom, BS2 8HW
        • Bristol Royal Infirmary
      • Leicester, United Kingdom, LE1 5WW
        • Leicester Royal Infirmary
      • London, United Kingdom, SW3 6NP
        • Royal Brompton Hospital
      • London, United Kingdom, SE1 9RT
        • Guy's and St Thomas' Hospital
      • Preston, United Kingdom, PR2 9HT
        • Royal Preston Hospital
      • Southampton, United Kingdom, SO16 6YD
        • Southampton General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All adult patients diagnosed with homogeneous or heterogeneous emphysema who are appropriate for Coil treatment based on the CE-Mark Approved IFU and who have been scheduled for treatment with the RePneu procedure will be eligible to participate in the Registry. If they agree and sign a consent form, they will then become study participants.

Description

Inclusion and exclusion criteria in the Registry are based on CE Mark approved indication and approved Instructions for Use. Patients enrolled and treated in the Registry study should meet the requirements of the PneumRx Endobronchial Coil System Instructions for Use.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Treatment
Patients treated with PneumRx Coil System
Device: PneumRx Coil System
Other Names:
  • LVRC
  • RePneu

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
Changes in Quality of Life (QOL) measures
Time Frame: 6 months and yearly up to three years post treatment 1
6 months and yearly up to three years post treatment 1

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Time Frame
Changes in Pulmonary Function and Exercise Capacity test results
Time Frame: 6 months and yearly up to three years post treatment 1
6 months and yearly up to three years post treatment 1
Safety including any device malfunction or failure(s)
Time Frame: 6 months and yearly up to three years post treatment 1
6 months and yearly up to three years post treatment 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Boston Scientific Corporation

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
PneumRx, Inc.

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Martin Hetzel, Prof., Krankenhaus vom Roten Kreuz
  • Principal Investigator: Christian Schumann, MD, Klinikenverbund Kempten-Oberallgäu

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 1, 2013

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 1, 2019

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 1, 2019

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 17, 2013

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 5, 2013

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 7, 2013

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 16, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 15, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • CLN0014

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings